Related Experiment Videos
[Diabetes and osteoporosis].
Iseki Takamoto1, Takashi Kadowaki
1Department of Metabolic Disease, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Clinical Calcium
|December 4, 2004
Summary
Diabetic osteopenia is linked to type 1 diabetes, but type 2 diabetes osteoporosis risk is debated. Diabetic complications and certain medications may influence bone metabolism and formation.
Area of Science:
- Endocrinology and Bone Metabolism
- Diabetes Mellitus Research
Context:
- Albright's concept of diabetic osteopenia has spurred research into bone mineral density (BMD) and osteoporosis risk in diabetes.
- Type 1 diabetes consistently shows an increased risk of osteoporosis.
- The association between type 2 diabetes and osteoporosis remains controversial, likely due to varied pathogenesis, clinical stages, and environmental factors.
Purpose:
- To explore the complex relationship between diabetes mellitus and bone health.
- To investigate the potential mechanisms underlying altered bone metabolism in diabetic patients.
- To review the impact of diabetic complications and related lifestyle disease medications on bone formation.
Summary:
- While osteoporosis is well-established in type 1 diabetes, its link to type 2 diabetes is less clear, with differing opinions.
- Pathogenic mechanisms like low insulin secretion, insulin resistance, hyperglycemia, adipocytokines, and diabetic triopathy are implicated in abnormal diabetic bone metabolism.
- Emerging evidence suggests that drugs used for lifestyle-related diseases, including statins, beta-blockers, and thiazolidinediones, might promote bone formation.
Impact:
- Clarifies the current understanding of osteoporosis risk in different types of diabetes.
- Highlights potential therapeutic targets and interventions for improving bone health in diabetic populations.
- Provides insights into the multifaceted effects of diabetes and its treatments on skeletal integrity.